Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #66717 on Amarin Corp Plc (AMRN)
ggwpq
12/15/15 10:10 AM
#66718 RE: zumantu #66717
sts66
12/15/15 1:20 PM
#66750 RE: zumantu #66717
The FDA has faced difficulty in its efforts to police drug marketing. In August, a court ruled the agency couldn’t bar Amarin Corp. from talking to doctors about unapproved uses of its fish-oil pill. While doctors are already allowed to prescribe drugs off-label, drugmakers have been restricted on promoting such uses. Pacira had also filed a lawsuit, since dropped, against the FDA in the Southern District of New York, the same court where Amarin won the ruling.